# Symbicort in Asthmatic Children - SEEDLING

> **NCT00651547** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 405 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** budesonide/formoterol
- **DRUG:** budesonide
- **DRUG:** formoterol

## Key facts

- **NCT ID:** NCT00651547
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2003-10
- **Target enrollment:** 405 (ESTIMATED)
- **Last updated:** 2009-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00651547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00651547, "Symbicort in Asthmatic Children - SEEDLING". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00651547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*